205678-26-8
Chemical Structure
SB-267268
- CAS No.: 205678-26-8
- Formula:C22H24F3N3O4
- Molecular Weight:451.44
IUPAC Name: (S)-2-(3-oxo-8-(3-(pyridin-2-ylamino)propoxy)-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl)acetic acid
InChIKey: PVDGZHKJXXVONO-INIZCTEOSA-N
SMILES: O=C(O)C[C@H]1C(N(CC(F)(F)F)CC2=CC(OCCCNC3=NC=CC=C3)=CC=C2C1)=O
Biological Activity: SB-267268 is a selective and nonpeptidic alpha(v)beta3 (αvβ3) and alpha(v)beta5 (αvβ5) integrins antagonist, with Kis of 0.9, 0.5 and 0.7 nM for human αvβ3, monkey αvβ3 and human αvβ5, respectively. SB-267268 inhibits human and mouse αvβ3 with IC50s of 0.68 and 0.29 nM, respectively. SB-267268 reduces angiogenesis and VEGF expression[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SB-267268 | 99.39% | SB-267268 is a selective and nonpeptidic alpha(v)beta3 (αvβ3) and alpha(v)beta5 (αvβ5) integrins antagonist, with Kis of 0.9, 0.5 and 0.7 nM for human αvβ3, monkey αvβ3 and human αvβ5, respectively. SB-267268 inhibits human and mouse αvβ3 with IC50s of 0.68 and 0.29 nM, respectively. SB-267268 reduces angiogenesis and VEGF expression. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.76
HY-19307SB-273005 -
Similarity Score 0.52
HY-150124K34c -
Similarity Score 0.52
HY-150124AK34c hydrochloride -
Similarity Score 0.50
HY-118788N-Desmethyl rosiglitazone -
Similarity Score 0.49
HY-139796ZYJ-34v -
Similarity Score 0.47
HY-148198S1P5 receptor agonist-1 -
Similarity Score 0.46
HY-100688ML390 -
Similarity Score 0.46
HY-128889FXIa-IN-1 -
Similarity Score 0.46
HY-139815ZYJ-34c -
Explore the MedChemAI to find more analogs
